Hecker Matthias, Weigand Markus A, Mayer Konstantin
Dtsch Med Wochenschr. 2017 Jan;142(2):96-101. doi: 10.1055/s-0042-105943. Epub 2017 Jan 23.
Acute respiratory distress syndrome (ARDS) is still regarded as an enormous medical challenge due to its complexity and poor prognosis. In spite of progress in research and therapy lethality remains unacceptably high. Besides established interventiotnal treatment options, numerous pharmacological approaches have been investigated in the past decades.
急性呼吸窘迫综合征(ARDS)因其复杂性和预后不良,至今仍被视为一项巨大的医学挑战。尽管在研究和治疗方面取得了进展,但其致死率仍然高得令人难以接受。除了既定的干预治疗方案外,在过去几十年里还研究了许多药物治疗方法。